Gathering life energy

Caring for human health

OEC    Mail   |

All
  • All
  • Products
  • News
  • Introduce the content
  • Enterprise gallery

Securities code:603520


R&D and innovation

R&D Overview

With several high-level R&D platforms, such as [Advanced Quality Research Platform, Crystallisation Platform, Microchannel Reaction Platform],our annual R&D investment could account for more than [6]% of  the sales revenue.

R&D Cooperation

Starry cooperates with Zhejiang University, Xiamen University, East China University of Science and Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Nanchang University, Yichun University, Taizhou Universityand other institutions.

R&D Results

We have more than [90] patent applications, undertaked a number of national and provincial research projects, and successfully passed the achievement examinations.

图片名称